| News
Basel initiative supports life sciences start-ups
01.02.2017
BaseLaunch, an accelerator initiative launched and run by the location promotion organisation BaselArea.swiss, is a new partner of the start-up accelerator Kickstart. Life sciences start-ups will be promoted through a second Kickstart programme.

(Img: DarkoStojanovic/Pixabay.com)
BaseLaunch, which will be launched on 22 February, is an accelerator initiative that aims to create the next generation of groundbreaking healthcare companies in the Basel region, according to a BaselArea.swiss announcement. The collaboration with Kickstart, one of the Europe’s largest multi-corporate start-up accelerators and an initiative of digitalswitzerland, will contribute towards accomplishing this objective. Kickstart is now starting a second programme.
“With the second edition taking place in Zurich and the extension of the programme to Basel, Kickstart will be one step closer to becoming the largest European start-up accelerator,” said Nicolas Bürer, managing director of digitalswitzerland, in a Kickstart statement. Kickstart describes Basel as a life sciences “hot spot” and says that the partnership will make it possible to “tap into the unexplored innovation potential”.
Kickstart Accelerator will select a shortlist of up to 30 start-ups that will be given the opportunity to develop their ideas in an 11-week programme at Impact Hub Zurich. In addition to life sciences, start-ups from the food sector, fintech, smart cities, and robotics and intelligent systems are also eligible.
The start-ups will receive support from experienced mentors and partner companies, and will have the chance to win up to CHF 25,000 as well as receiving a monthly stipend.
“Cooperation between the start-ups and corporate partners will allow the entrepreneurs to benefit from the corporates’ know-how and large customer networks, as well as enable them to develop new technologies and disruptive products together,” commented Carola Wahl, head of transformation and market management at AXA Winterthur, one of the corporate partners.
Interested start-ups can apply at Kickstart Accelerator.
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Clinerion is now part of Citeline
Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...
Read MoreKUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read MoreBSI integrating AI from Parashift in banking software
Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...
Read MoreUptownBasel joins IBM Quantum Network
UptownBasel is partnering with IBM. The emerging competence center for Industry 4.0 will provide its partners with the IBM Quantum...
Read MoreSouth Korean pharma firms show interest in the Basel Area
Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...
Read More